Levels of IL-1β were found to be elevated in cerebrospinal fluid (CSF), plasma samples or post-mortem brain tissue of AD patients [16–19], while other studies reported no changes in IL-1β in serum or CSF of AD patients compared to controls [20, 21]. The gene discussed is IL1B; the disease is Alzheimer disease.